NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ELLEX MEDICAL LASERS LIMITED (ELX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of ELX: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Adelaide
Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000ELX4
Address: 82 Gilbert Street, ADELAIDE, SA, AUSTRALIA, 5000
Tel:  08 8104 5200Fax: 08 8104 5231

Date first listed: 12/10/1987

Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Design and manufacture of ophthalmic laser systems

News & Events

Expand this box to read and print

name changed to Nova Eye Medical Limited

03/07/2020

The suspension of trading in the securities of Ellex Medical Lasers Limited will be lifted immediately, following the release by ELX of an announcement regarding an agreement for the sale of the Ellex Lasers & Ultrasound business.

24/12/2019

A$100 million in cash, representing 1.5x Lasers & Ultrasound FY19 revenues1 and 10.6x FY19 EBITDA. Net cash proceeds of approximately $97 million, after adjustments for Ellex iTrack, 2RT and allocated corporate expenditure prior to the completion date. Ellex shareholders to vote on the proposed sale, with transaction close expected by late March 2020. Ellex Board of Directors unanimously recommend the transaction. Ellex Board committed to returning majority of net funds received to shareholders. Post transaction, Ellex will be debt-free and will be primarily focused on devices to treat glaucoma in a growing, underpenetrated global market and 2RT for macular degeneration.

24/12/2019

The suspension is requested until the commencement of trading on Wednesday 15 January 2020 or such earlier time as Ellex makes an announcement to the market in respect of the proposed transaction.

12/12/2019

The company releases the results of its meeting.

28/11/2019

The company releases 2019 AGM Presentation.

28/11/2019

The company releases its CEO address.

28/11/2019

The company releases the Chairman's Address to Shareholders.

28/11/2019

The securities of Ellex Medical Lasers Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of ELX, pending the release of an announcement regarding a proposed sale of a key business segment.

28/11/2019

name changed from Gemstone Corporation of Australia Limited

31/07/2001

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    26/10/2019Mike Southard20,000$0.746$14,910
    28/05/2018Rahmon Coupe26,251$0.590$15,488
    07/05/2018Rahmon Coupe13,749$0.740$10,174
    10/10/2016Rahmon Coupe-60,000$1.227$73,600
    04/10/2016Rahmon Coupe-54,600$1.195$65,246

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Victor PrevinExecutive Chairman16/07/2001
    Rahmon CoupeIndependent Director17/05/2013
    Alexander SundichNon Exec Director25/07/2005
    Mike ManganoDirector02/07/2018
    Mike SouthardDirector02/07/2018
    Simon GrayCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Maria MaieliCEO19/07/201918/02/2020
    Giuseppe CanalaNon Exec Director17/10/200827/11/2019
    Gerard WallaceCEO08/04/201919/07/2019
    Tom SpurlingCEO31/03/201105/04/2019
    Meera VermaIndependent Director17/05/201315/05/2018
    Malcolm PlunkettExecutive Director17/10/200804/04/2013

    Date of first appointment, title may have changed.